Knollwood Investment Advisory LLC Takes $3.33 Million Position in Omada Health, Inc. $OMDA

Knollwood Investment Advisory LLC acquired a new stake in Omada Health, Inc. (NASDAQ:OMDA) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 210,763 shares of the company’s stock, valued at approximately $3,326,000.

Several other hedge funds also recently modified their holdings of OMDA. Quarry LP bought a new stake in shares of Omada Health in the 4th quarter valued at $29,000. TD Waterhouse Canada Inc. bought a new stake in shares of Omada Health in the 4th quarter valued at $32,000. Raymond James Financial Inc. bought a new stake in shares of Omada Health in the 2nd quarter valued at $32,000. Inlight Wealth Management LLC bought a new stake in shares of Omada Health in the 4th quarter valued at $45,000. Finally, Strs Ohio increased its stake in shares of Omada Health by 151.0% in the 4th quarter. Strs Ohio now owns 4,267 shares of the company’s stock valued at $67,000 after acquiring an additional 2,567 shares in the last quarter.

Insider Transactions at Omada Health

In other Omada Health news, President Wei-Li Shao sold 2,829 shares of Omada Health stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $12.71, for a total transaction of $35,956.59. Following the transaction, the president directly owned 328,850 shares of the company’s stock, valued at $4,179,683.50. The trade was a 0.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 6.38% of the company’s stock.

Analysts Set New Price Targets

OMDA has been the subject of several research analyst reports. JPMorgan Chase & Co. lowered their price objective on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research note on Thursday, March 12th. Citizens Jmp lifted their price objective on shares of Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a research note on Friday, May 8th. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a research note on Friday, May 8th. BMO Capital Markets lowered their price objective on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Omada Health has a consensus rating of “Moderate Buy” and an average target price of $22.91.

Omada Health Trading Down 3.3%

NASDAQ OMDA opened at $17.14 on Friday. The company has a fifty day simple moving average of $15.35 and a 200 day simple moving average of $14.83. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The company has a market cap of $1.02 billion and a P/E ratio of -63.48.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The business had revenue of $78.05 million during the quarter. Sell-side analysts predict that Omada Health, Inc. will post -0.01 EPS for the current year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.